EC Number   |
Specific Activity Minimum [µmol/min/mg] |
Specific Activity Maximum [µmol/min/mg] |
Reference |
|---|
    3.5.4.4 | -999 |
- |
326 nkat/mg with substrate adenine, reaction of EC 3.5.4.2, adenine deaminase |
696861 |
| 3.5.4.4 | -999 |
- |
75.7 U/g tissue, ADAII |
686612 |
| 3.5.4.4 | -999 |
- |
activity in cerebrospinal fluid of healthy persons and tuberculous or non-infectious meningitis patients |
668232 |
| 3.5.4.4 | -999 |
- |
ADA activity is observed in the parasites at all concentrations tested and its activity is proportional to the concentration of protein, ranging between 0.64 and 2.24 U/l in the lowest and highest concentration of protein, respectively |
719422 |
| 3.5.4.4 | -999 |
- |
adenosine deaminase activity is higher in young rat brains when compared to the 60-day-old rats and is higher in hippocampus when compared to the cerebral cortex |
695973 |
| 3.5.4.4 | -999 |
- |
enzyme activity in nasal polyps and nasal mucosa |
670464 |
| 3.5.4.4 | -999 |
- |
enzyme activity in T-lymphocytes of healthy persons and multiple sclerosis patients |
670393 |
| 3.5.4.4 | -999 |
- |
no activity with substrate 9H-(1-deoxy-3,4-O-isopropylidene-beta-D-psicofuranosyl)adenine, adenosine deaminase aptly transforms substrates largely modified at the 2Â’- and 3Â’-O-positions, whereas C-modification at the 1Â’-position prevents the adenosine deaminase-catalyzed deamination |
696676 |
| 3.5.4.4 | -999 |
- |
patients with fever attack have significantly higher adenosine deaminase levels in plasma compared to attack-free periods and healthy control group |
697735 |
| 3.5.4.4 | -999 |
- |
relative substrate specificity in nmol NH3/min/mg of protein, adenosine 11.2, 2Â’-deoxyadenosine 23.6, guanosine 1.8, 2Â’-deoxyguanosine 2.0 for the soluble fraction, adenosine 20.9, 2Â’-deoxyadenosine 5.4, guanosine 1.7, 2Â’-deoxyguanosine 1.8 for the membrane-bound adenosine deaminase |
697462 |
